clinical trial · NCT05022004
A Therapeutic Equivalence Study in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension
Primary Open Angle GlaucomaOcular HypertensionBrinzolamide ophthalmic suspensionAzopt®
brief summary
This is a randomized, Investigator-masked, multi-center, parallel group, therapeutic equivalence study with clinical endpoint.
started
Dec 20, 2021
primary completion
Dec 29, 2022
completion
Jan 6, 2023
last updated
Jan 18, 2024
official title
Therapeutic Equivalence Study of Generic Brinzolamide 1% Ophthalmic Suspension Compared to Reference Listed Drug Azopt® (Brinzolamide) Ophthalmic Suspension 1% in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension.
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol